US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Articles published by Renovaro Biosciences Inc.

News headline image
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB
News headline image
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB
News headline image
Statement of Renovaro Inc
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB
News headline image
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB
News headline image
AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB
News headline image
Renovaro Biosciences Announces Results of Special Meeting of Shareholders
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB
News headline image
Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB
News headline image
Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB
News headline image
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB
News headline image
Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB
News headline image
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB
News headline image
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB
News headline image
Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB
News headline image
Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB
News headline image
AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer
From Renovaro Biosciences Inc.
Via GlobeNewswire
Tickers RENB